COVID-19

Prolonged COVID-19 symptoms, including severe fatigue, were more common among patients infected during the pre-delta period compared with the later delta and omicron periods, researchers found.

Although the breakthrough infection rate has been high in patients using rituximab during the later stages of the COVID-19 pandemic, a small proportion of those who are fully vaccinated develop severe outcomes, according to data.

Antibiotic prescribing was high among patients with COVID-19, but researchers found that antimicrobial stewardship programs with prospective audit and feedback helped optimize antibiotic treatments among these patients.

Researchers determined that nearly 500,000 people from England, Scotland and Wales should have initiated BP-lowering medication but did not during the first year-plus of the COVID-19 pandemic.

Key risk factors that may predict severe disease in patients with MIS-C include fever greater than 103.1 degrees Fahrenheit, central nervous system involvement and left ventricular dysfunction, according to data published in Rheumatology.

The Biden administration will end the public health emergency and national emergency declarations related to COVID-19 on May 11, according to a White House statement.

In the United States, there were more than 600 excess deaths among physicians from March 2020 to December 2021, according to a research letter published in JAMA Internal Medicine.

Data show more than 11% of adults hospitalized for COVID-19 experienced at least one acute CV event, doubling their risk for ICU admission or in-hospital death, researchers reported.

During the COVID-19 pandemic, loneliness, family conflict and difficultly accessing health care raised the risk for first-time and recurrent depression among older adults with asthma, according to a study published in Respiratory Medicine.

Although roughly 77% of older adults globally have been vaccinated against COVID-19, researchers found wide disparities in vaccination rates based on income levels.